Abstract
Cyphellophora guyanensis (n = 15), other Cyphellophora species (n = 11), Phialophora europaea (n = 43), and other Phialophora species (n = 12) were tested in vitro against nine antifungal drugs. The MIC(90)s across all of the strains (n = 81) were, in increasing order, as follows: posaconazole, 0.063 μg/ml; itraconazole, 0.5 μg/ml; voriconazole, 1 μg/ml; micafungin, 1 μg/ml; terbinafine, 2 μg/ml; isavuconazole, 4 μg/ml; caspofungin, 4 μg/ml; fluconazole, 8 μg/ml; amphotericin B, 16 μg/ml.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amphotericin B / pharmacology
-
Antifungal Agents / pharmacology*
-
Caspofungin
-
Echinocandins / pharmacology
-
Fluconazole / pharmacology
-
Itraconazole / pharmacology
-
Lipopeptides / pharmacology
-
Micafungin
-
Microbial Sensitivity Tests
-
Mitosporic Fungi / drug effects*
-
Mitosporic Fungi / growth & development
-
Naphthalenes / pharmacology
-
Nitriles / pharmacology
-
Phialophora / drug effects*
-
Phialophora / growth & development
-
Pyridines / pharmacology
-
Pyrimidines / pharmacology
-
Terbinafine
-
Triazoles / pharmacology
-
Voriconazole
Substances
-
Antifungal Agents
-
Echinocandins
-
Lipopeptides
-
Naphthalenes
-
Nitriles
-
Pyridines
-
Pyrimidines
-
Triazoles
-
Itraconazole
-
isavuconazole
-
posaconazole
-
Amphotericin B
-
Fluconazole
-
Caspofungin
-
Terbinafine
-
Voriconazole
-
Micafungin